FB2026_03 , released September 17, 2026
Reference Report
Open Close
Reference
Citation
Chauhan, B.S., Rai, A., Sonkar, A.K., Tripathi, K., Upadhyay, S., Mishra, L., Srikrishna, S. (2022). Neuroprotective Activity of a Novel Synthetic Rhodamine-Based Hydrazone against Cu2+-Induced Alzheimer's Disease in Drosophila.  ACS Chem. Neurosci. 13(10): 1566--1579.
FlyBase ID
FBrf0253525
Publication Type
Research paper
Abstract
A new rhodamine-based probe 3,5-di-tert-butylsalicylaldehyde rhodamine hydrazone (RHTB) has been synthesized and well characterized using spectroscopic techniques and single-crystal X-ray crystallography. Among several metal ions, it selectively detects Cu2+ ions as monitored by UV-Vis and emission spectral titrations. It displays "turn on" behavior owing to the opening of a spirolactum ring and the presence of 3,5-di-tert-butyl as an electron releasing group. Further, Cu2+ ions play a pivotal role in extracellular aggregation of Aβ42 peptides. So far, we know probably that there are no promising drugs available in this regard. Hence, countering the Cu2+ ions by RHTB chelation against orally administered Cu2+ ion-induced neurotoxicity in the eye tissue of Drosophila expressing human Aβ42 (amyloid-β42) has been tested. The present study involves in vivo and in silico approaches. They reveal the therapeutic potential of RHTB against Cu2+ ion-induced Aβ42 toxicity in Alzheimer's disease (AD) model of Drosophila.
PubMed ID
PubMed Central ID
Associated Information
Comments
Associated Files
Other Information
Secondary IDs
    Language of Publication
    English
    Additional Languages of Abstract
    Parent Publication
    Publication Type
    Journal
    Abbreviation
    ACS Chem. Neurosci.
    Title
    ACS chemical neuroscience
    ISBN/ISSN
    1948-7193
    Data From Reference
    Chemicals (1)
    Genes (1)
    Human Disease Models (1)